With respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity
Biao He, PhD
Advertisement
Articles by Biao He, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Scrutiny of GLP-1 Compounding Is Just Getting Started, Expert Says
2
Menin Inhibitors in AML: Frequently Asked Questions
3
From Misnomer to Meaning: A Patient-Centered Shift from PCOS to PMOS
4
FDA Approves Veligrotug-vvze as First Agent With Data in Both Active and Chronic Thyroid Eye Disease
5